Services
Pharmaceutical
Events
Pharmaceutical
The Challenge
Drug developing companies face the need to optimize LEAD identification and corresponding screening projects both in terms of cost effectiveness and probability of success. Especially for companies without in-house NP capabilities, they need to rely on a partner who provides both strategic and operative expertise in order to carry out assignments on a “one-stop-basis”.
IMD’s uniqueness
IMD has 20 years of experience with screening projects in numerous indication areas as part of a major pharmaceutical company. Our solid understanding of pharmaceutical R&D processes makes us an excellent and reliable partner to enrich your LEAD identification strategy with our NP-based chemical matter. Our huge sample collection and the capability to tailor and focus libraries and screening pools for higher probability of success assure better results and higher efficiency.